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Background
Chemotherapeutically induced myocardial injury con-
tinues to pose a major problem. The exact mechanism
of drug-related cardiomyopathy (DRC) is still poorly
understood. An early diagnosis of cardiotoxicity and the
ability to predict patients at risk are important for pre-
venting chronic heart failure. The guidelines for non-
invasive cardiac imaging to screen for DRC show limita-
tions in early identification of patients at risk, currently
relying on left ventricular (LV) ejection fraction (EF) for
establishing high risk. Contrast enhanced cardiac mag-
netic resonance imaging (ce-CMR) may offer a stronger
screening approach, especially since it can assess the
right ventricle (RV) and detect early changes in response
to chemotherapy.
Methods
51 patients (31 men, 20 women) with various types of
cancer, who underwent chemotherapy with a variety of
regimens, were assessed with ce-CMR within 6 months
of chemotherapy. Ce-CMR results for both RV and LV
were compared with published data (Hudsmith et al.,
JACC, 2005) using the 1-sample Student t test. A p
value <0.05 was considered significant. Descriptive sta-
tistics are described as percentages.
Results
In patients, EF was lower in both ventricles:
RVEF=54.8% and LVEF= 53.6% vs. controls: RVEF=61%
and LVEF= 69%, (p=0.002, p<0.001, respectively). Right
and left stroke volumes (SV) were also lower: RVSV=
69.1 mL, LVSV= 76.3 mL, vs. controls: RVSV and
LVSV=104 mL (p≤ 0.001). Both ventricles demonstrated
decreased end diastolic volumes (EDV): RVEDV=132.8
ml, LVEDV=144.4 ml, vs. controls: RVEDV =173 ml
and LVEDV=150ml, though only statistically significant
in the RV (p<0.001). An elevated end systolic volume
(ESV) was also noted: RVESV=70.1 mL, LVESV=67.4
mL vs. controls: RVESV=69 ml and LVESV=47 ml,
though only statistically significant in the LV (p<0.001).
Interestingly, with respect to wall motion abnormal-
ities, 4 (8%) patients demonstrated segmental abnormal-
ities in the RV. In the LV, 15 patients (29%)
demonstrated wall motion abnormalities, involving mul-
tiple segments (13/15 at the base, 13/15 at mid level,
and 14/15 in the apex). Only 1 (2%) patient demon-
strated delayed enhancement (DE) in the RV, while 10
patients (20%) demonstrated DE in the LV, also invol-
ving multiple segments: 10/10 in the basal LV, 8/10 in
the mid LV, and 7/10 in the apex.
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Figure 1 Delayed enhancement involving the left ventricle in a 61
year old male with Acute Myelogenous Leukemia.
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Conclusions
Decreased RVEF, LVEF and ventricular volumes, as well
as wall motion abnormalities and presence of DE
regions in non-coronary pattern of distribution, may
represent early changes secondary to chemotherapy.
Earlier detection of DRC may allow for earlier initiation
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